Activation by β-carbolines of G-proteins in HL-60 membranes and the bovine retinal G-protein transducin in a receptor-independent manner

Biochemical Pharmacology

Volumn 53, Issue 11, 1997, Pages 1621-1626

  Klinker, Jan F ^a   Seifert, Roland ^a   Damm, Henning ^b   Rommelspacher, Hans ^b  

^a STANFORD UNIVERSITY   (United States)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

carbolines; G protein; GTPase; HL 60 cells; Pertussis toxin; Transducin

Indexed keywords

BETA CARBOLINE; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE DIPHOSPHATE; GUANOSINE TRIPHOSPHATASE; HARMAN; MASTOPARAN; PERTUSSIS TOXIN; TRANSDUCIN; TRYPTOLINE;

ANIMAL TISSUE; ARTICLE; CATTLE; CELL STRAIN HL 60; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; HUMAN; HUMAN CELL; HYDROLYSIS; NONHUMAN; PRIORITY JOURNAL; RETINA; RETINA ROD OUTER SEGMENT; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

CARBOLINES; CELL MEMBRANE; ENZYME ACTIVATION; GTP PHOSPHOHYDROLASES; GTP-BINDING PROTEINS; HARMINE; HL-60 CELLS; HUMANS; PEPTIDES; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSDUCIN; WASP VENOMS;

EID: 0030841708     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(97)00065-8     Document Type: Article

References (32)

1. Biagi GL, Pietrogrande MC, Barbaro AM, Guerra MC, Borea PA and Cantelli Forti G, Study of the lipophilic character of a series of β-carbolines. J Chromatogr 469: 121-126, 1989.
2. Rommelspacher H, May T and Susilo R, β-carbolines and tetrahydroisoquinolines: Detection and function in mammals. Planta Med 57: 85-92, 1991.
3. Rommelspacher H, Schmidt LG and May T, Plasma norharman (β-carboline) levels are elevated in chronic alcoholics. Alcoholism: Clin Exp Res 15: 553-559, 1991.
4. Naranjo C, Psychotropic properties of the harmala alkaloids. In: Ethnopharmacologic Search for Psychoactive Drugs (Eds. Efron DH, Holmstedt B and Kline NS), pp. 385-391. Raven Press, NY, 1979.
5. 3H]β-carboline) in the rat brain. Eur J Pharmacol 147: 163-171, 1988.
6. May T, Greube A, Strauss S, Heinicke D, Lehmann J and Rommelspacher H, Comparison of the in vitro binding characteristics of the β-carbolines harman and norharman in rat brain and liver and in bovine adrenal medulla. Naunyn Schmiedeberg's Arch Pharmacol 349: 308-317, 1994.
7. 3H]β-carboline) binds reversibly and with high affinity to a specific binding site in rat liver. Neurochem Res 18: 1029-1031, 1993.
8. Müller WE, Fehske KJ, Borbe HD, Wollert U, Nanz C and Rommelspacher H, On the neuropharmacology of harman and other β-carbolines. Pharmacol Biochem Behav 14: 693-699, 1981.
9. Nimit Y, Schulze I, Cashaw JL, Ruchirawat S and Davis VE, Neurotransmitter, opiate, and benzodiazepine receptor binding of tetrahydroisoquinolines and β-carbolines in brain membranes. In: Beta-Carbolines and Tetrahydroisoquinolines (Eds. Bloom FE, Barchas J, Sander M and Usdin E), pp. 311-320, Liss, NY, 1982.
10. Airaksinen MM, Lecklin A, Saano V, Tuomisto L, Gynther J, Tremorigenic effect and inhibition of tryptamine and serotonin receptor binding by β-carbolines. Pharmacol Toxicol 60: 5-8, 1987.
11. Strömbom J, Jokela R, Saano V and Rolfsen W, Binding of strychnocarpine and related β-carbolines to brain receptors in vitro. Eur J Pharmacol 214: 165-168, 1992.
12. Braestrup C, Schmiechen R, Neef G, Nielsen M and Petersen EN, Interaction of convulsive ligands with benzodiazepine receptors. Science 216: 1241-1243, 1982.
13. i-proteins in HL-60 membranes indirectly through interaction with nucleoside diphosphate kinase. Biochem J 304: 377-383, 1994.
14. i-proteins in dibutyryl cyclic AMP-differentiated HL-60 cells. Biochem J 296: 245-251, 1993.
15. i-proteins in HL-60 cells through a mechanism that is independent of known histamine receptor sub-types. Mol Pharmacol 45: 578-586, 1994.
16. Hagelüken A, Grünbaum L, Klinker JF, Nürnberg B, Harhammer R, Schultz G, Leschke C, Schunack W and Seifert R, Histamine receptor-dependent and/or -independent activation of guanine nucleotide-binding proteins by histamine and 2-substituted histamine derivatives in human leukemia (HL-60) and human erythroleukemia (HEL) cells. Biochem Pharmacol 49: 901-914, 1995.
17. 1-receptor antagonists in HL-60 cells, basophils and mast cells. Biochem Pharmacol 51: 125-131, 1996.
18. Hagelüken A, Nürnberg B, Harhammer R, Grünbaum L, Schunack W and Seifert R, The class III antiarrhythmic drug amiodarone directly activates pertussis toxin-sensitive G-proteins. Mol Pharmacol 47: 234-240, 1995.
19. Hagelüken A, Grünbaum L, Nürnberg B, Harhammer R, Schunack W and Seifert R, Lipophilic β-adrenoceptor antagonists and local anesthetics are effective direct activators of G-proteins. Biochem Pharmacol 47: 1789-1795, 1994.
20. Higashijima T, Uzu S, Nakajima T and Ross EM, Mastoparan, a peptide toxin from wasp venom, mimics receptors by activating GTP-binding regulatory proteins (G-proteins). J Biol Chem 263: 6491-6494, 1988.
21. Ross EM, and Higashijima T, Regulation of G-protein activation by mastoparans and other cationic peptides. Methods Enzymol 237: 26-37, 1994.
22. Klinker JF, Laugwitz K-L, Hagelüken A and Seifert R, Mastoparan activates GTP formation and high-affinity GTP hydrolysis in various cell membranes: G-protein activation via nucleoside diphosphate kinase may be a general mechanism of mastoparan action. Biochem Pharmacol 51: 217-223, 1996.
23. Hagelüken A, Burde R, Nürnberg B, Harhammer R, Buschauer A and Seifert R, Cationic-amphiphilic arpromidine-derived guanidines and a histamine trifluoromethyl-toluidide derivative may activate pertussis toxin-sensitive G-proteins by a receptor-independent mechanism. Naunyn Schmiedeberg's Arch Pharmacol 351: 305-308, 1995.
24. Vejdelek ZJ, Trcka V and Protiva M, Synthetic experiments in the group of hypotensive alkaloids. XXI. Chemistry of 1,2,3,4-tetrahydronorharman-1-carboxylic acid and derivatives. J Med Pharm Chem 3: 427-440, 1961.
25. 32P-labled nucleoside triphosphates, nicotinamide adenine dinucleotide, and cyclic nucleotides for use in determining adenylyl and guanylyl cyclase and cyclic nucleotide phosphodiesterase. Methods Enzymol 195: 29-44, 1991.
26. Wenzel-Seifert K and Seifert R, Nucleotide-, chemotactic peptide-and phorbol ester-induced exocytosis in HL-60 leukemic cells, Immunobiology 181: 298-316, 1990.
27. Papermaster DS and Dreyer WJ, Rhodopsin content in the outer segment membranes of bovine and frog retinal rods. Biochemistry 13: 2438-2444, 1974.
28. Kroll S, Phillips WJ and Cerione RA, The regulation of the cyclic GMP phosphodiesterase by the GDP-bound form of the α-subunit of transducin. J Biol Chem 264: 4490-4497, 1989.
29. Peterson GL, Determination of total protein Methods Enzymol 91: 95-119, 1983.
30. Klinker JF and Seifert R, Synthetic lipopeptides activate nucleoside diphosphate kinase in HL-60 membranes, Biochem Biophys Res Commun 209: 575-581, 1995.
31. Matsubara K, Collins MA, Akane A, Ikebuchi L, Neafsey EJ, Kagawa M and Shiono H, Potential bioactivated neurotoxicants, N-methylated β-carbolinium ions, are present in human brain. Brain Res 610: 90-96, 1993.
32. Seeman P, Anti-schizophrenic drugs-membrane receptor sites of action. Biochem Pharmocol 26: 1741-1748, 1977.